UK-based, Dxcover (previously Clinspec Diagnostics) is a clinical-stage diagnostics company. The startup has developed a liquid biopsy platform - powered by “attenuated total reflectance, fourier transform infrared spectroscopy” “of pan-omic biomarkers” - which analyzes patient blood samples (with the help of AI) to detect the presence (or absence) of cancer. It generates compelling clinical data with high accuracy detection (80-90%) of Stage I & II brain tumors, particularly Glioblastoma Multiforme (the most aggressive type). The firm has also published data with “exceptional potential” on detecting pancreatic cancer as well as 6 other types (lung, colon, breast, prostate, ovarian & kidney) (the 8-types combined, account for 65% of the global cancer burden). Various patents have already...

UK-based, Archangel Lightworks (Archangel) is building TERRA-M, a miniature & portable optical ground station, which enables secure, resilient & high-volume connectivity to & from space using laser-based communication (lasercom) (sometimes referred to as free space optics). (ps: on the secure-side, the startup closely collaborates with Singapore-based SpeQtral, which designs & manufacturers satellite-based quantum communication systems & provides it with end-to-end distribution of quantum encryption keys). <Quick primer on lasers: they can transfer 10-100x more info to & from satellites than radio waves (commonly used). They’re also cheaper (radio frequency spectrum is limited/ expensive) (lasers are license free) & safer from attacks and disruptions (e.g. a space-based lasercom internet won’t suffer from undersea cables linking continents...